Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase S01.215: coagulation factor VIIa

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(References are filtered for relevance to Therapeutic. To remove the filter click here. See explanation.)

    2018
  1. Habib,A.M., Calafiore,A.M., Cargoni,M., Foschi,M. and Di Mauro,M.
    Recombinant activated factor VII is associated with postoperative thromboembolic adverse events in bleeding after coronary surgery
    Interact Cardiovasc Thorac Surg27, 350-356. PubMed  Europe PubMed DOI  U
  2. Rajpurkar,M. and Cooper,D.L.
    Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency
    J Blood Med9, 227-239. PubMed  Europe PubMed DOI  U
    3. 2017
  3. Di Minno,M.N.D., Ambrosino,P., Myasoedova,V., Amato,M., Ventre,I., Tremoli,E. and Minno,A.D.
    Recombinant activated factor VII (eptacog alfa activated NovoSeven (R) ) in patients with rare congenital bleeding disorders. A systematic review on its use in surgical procedures
    Curr Pharm Des23, 1125-1131. PubMed  Europe PubMed  V  U
    4. 2016
  4. Faranoush,M., Abolghasemi,H., Mahboudi,F., Toogeh,G., Karimi,M., Eshghi,P., Managhchi,M., Hoorfar,H., Dehdezi,B.K., Mehrvar,A., Khoeiny,B., Vaziri,B., Kamyar,K., Heshmat,R., Baghaeipour,M.R., Mirbehbahani,N.B., Fayazfar,R., Ahmadinejad,M. and Naderi,M.
    A comparison of efficacy between recombinant activated factor VII (Aryoseven) and Novoseven in patients with hereditary FVIII deficiency with inhibitor
    Clin Appl Thromb Hemost22, 184-190. PubMed  Europe PubMed DOI  U
  5. Habib,A.M., Mousa,A.Y. and Al-Halees,Z.
    Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
    J Saudi Heart Assoc28, 222-231. PubMed  Europe PubMed DOI  U
  6. Ma,A.D., Kessler,C.M., Al-Mondhiry,H.A., Gut,R.Z. and Cooper,D.L.
    Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study
    Blood Coagul Fibrinolysis27, 753-760. PubMed  Europe PubMed DOI  U
    7. 2015
  7. Hedner,U.
    Recombinant activated factor VII: 30 years of research and innovation
    Blood Rev29 Suppl 1, S4-S8. PubMed  Europe PubMed DOI  U
    8. 2014
  8. Faydhi,A.A., Kassem,Y.A., Al-Shabassy,A.M., Ahmed,S. and Al-Shareef,A.
    Recombinant activated factor VII as treatment for intractable haemorrhage
    East Mediterr Health J19 Suppl 3, S184-S189. PubMed  Europe PubMed  U
    9. 2013
  9. Bartosh,N.S., Tomlin,T., Cable,C. and Halka,K.
    Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven((R)))
    Clin Pharmacol5, 53-58. PubMed  Europe PubMed DOI  M  U
  10. Tagliaferri,A. and Franchini,M.
    The expanding role of prophylaxis with recombinant activated factor VII
    Blood Transfus11, 12-13. PubMed  Europe PubMed DOI  U
    11. 2012
  11. Mandal,S.K., Sagar,G., Sahoo,M. and Jasuja,S.
    Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis
    Indian J Nephrol22, 130-132. PubMed  Europe PubMed DOI  U
  12. Morel,N., Chabarttier,C., Merson,L., Lelias,A., Bernard,J.C., Delaunay,F., Dabadie,P. and Janvier,G.
    Advantage of using a recombinant activated factor VII in traumatic haemorrhagic shock: The Bordeaux experience
    J Emerg Trauma Shock5, 143-148. PubMed  Europe PubMed DOI  U
  13. Morfini,M., Jimenez-Yuste,V., Eichler,H., Fischer,R., Kirchmaier,C.M., Scharling,B. and Bjerre,J.
    Pharmacokinetic properties of two different recombinant activated factor VII formulations
    Haemophilia18, 431-436. PubMed  Europe PubMed DOI  U
  14. Tokgoz,H., Caliskan,U., Lavigne-Lissalde,G. and Giansily-Blaizot,M.
    Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII
    Haemophilia18, e25-e27. PubMed  Europe PubMed DOI  U
    15. 2011
  15. Christensen,A., Jensen,J.T., Nohr,A.M. and Cooper,D.L.
    Room-temperature-stable recombinant activated coagulation factor VII recombinant: chemical and microbiologic stability over 24 hours during continuous in vitro infusion
    Clin Ther33, 1997-2001. PubMed  Europe PubMed DOI  U
  16. Dutton,R.P., Parr,M., Tortella,B.J., Champion,H.R., Bernard,G.R., Boffard,K., Bouillon,B., Croce,M.A., Dimsits,J., Holcomb,J.B., Leppaniemi,A., Vincent,J.L. and Hauser,C.J.
    Recombinant activated factor VII safety in trauma patients: results from the CONTROL trial
    J Trauma71, 12-19. PubMed  Europe PubMed DOI  U
  17. Franchini,M., Targher,G. and Lippi,G.
    Safety of recombinant activated factor VII in randomized clinical trials
    N Engl J Med364, 575-576. PubMed  Europe PubMed DOI  U
  18. Krisl,J.C., Meadows,H.E., Greenberg,C.S. and Mazur,J.E.
    Clinical usefulness of recombinant activated factor VII in patients with liver failure undergoing invasive procedures
    Ann Pharmacother45, 1433-1438. PubMed  Europe PubMed DOI  U
  19. Margaritis,P., Roy,E., Faella,A., Downey,H.D., Ivanciu,L., Pavani,G., Zhou,S., Bunte,R.M. and High,K.A.
    Catalytic domain modification and viral gene delivery of activated factor VII confers hemostasis at reduced expression levels and vector doses in vivo
    Blood117, 3974-3982. PubMed  Europe PubMed DOI  U
  20. Morfini,M. and Bjerre,J.
    Pharmacokinetics and safety of a 270 mcg kg-1 dose of room temperature stable recombinant activated factor VII in patients with haemophilia
    Haemophilia17, 860-866. PubMed  Europe PubMed DOI  U
  21. Patel,A., Cooper,N. and Laffan,M.A.
    Safety of recombinant activated factor VII in randomized clinical trials
    N Engl J Med364, 574-576. PubMed  Europe PubMed DOI  U
  22. Ponschab,M., Landoni,G., Biondi-Zoccai,G., Bignami,E., Frati,E., Nicolotti,D., Monaco,F., Pappalardo,F. and Zangrillo,A.
    Recombinant activated factor VII increases stroke in cardiac surgery: a meta-analysis
    J Cardiothorac Vasc Anesth25, 804-810. PubMed  Europe PubMed DOI  U
  23. Tiede,A., Friedrich,U., Stenmo,C., Allen,G., Giangrande,P., Goudemand,J., Hay,C., Holmstrom,M., Klamroth,R., Lethagen,S., McKenzie,S., Miesbach,W., Negrier,C., Yuste,V.J. and Berntorp,E.
    Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)
    J Thromb Haemost9, 1191-1199. PubMed  Europe PubMed DOI  U
    24. 2010
  24. AlGahtani,F.H., Alshaikh,M. and AlDiab,A.
    Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients
    Ann Saudi Med30, 198-202. PubMed  Europe PubMed DOI  U
  25. Grottke,O., Henzler,D. and Rossaint,R.
    Activated recombinant factor VII (rFVIIa)
    Best Pract Res Clin Anaesthesiol24, 95-106. PubMed  Europe PubMed DOI  E  U
    26. 2009
  26. Bilic,E., Rajic,L., Femenic,R., Konja,J., Vucic,K., Novak,M., Cvitkovic,M., Galic,S. and Krmek,N.
    Recombinant activated factor VII controls chemotherapy-related hemorrhage in patients with solid intra-abdominal tumors: a report of three pediatric cases
    Acta Clin Croat48, 161-166. PubMed  Europe PubMed  U
  27. Bomken,C., Mathai,S., Biss,T., Loughney,A. and Hanley,J.
    Recombinant activated factor VII (rFVIIa) in the management of major obstetric haemorrhage: a case series and a proposed guideline for use
    Obstet Gynecol Int2009, 364843-364843. PubMed  Europe PubMed DOI  U
  28. Carmo,K.A., O'Brien,K., Teo,J. and Schell,D.
    Traumatic bleeding at birth treated with factor VII
    J Paediatr Child Health45, 68-70. PubMed  Europe PubMed DOI  U
  29. Franchini,M., Manzato,F., Salvagno,G.L., Montagnana,M., Zaffanello,M. and Lippi,G.
    Prophylaxis in Congenital Hemophilia with Inhibitors: The Role of Recombinant Activated Factor VII
    Semin Thromb Hemost35, 814-819. PubMed  Europe PubMed DOI  U
  30. Gill,R., Herbertson,M., Vuylsteke,A., Olsen,P.S., von Heymann,C., Mythen,M., Sellke,F., Booth,F. and Schmidt,T.A.
    Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery
    Circulation120, 21-27. PubMed  Europe PubMed DOI  U
    31. 2006
  31. Rizoli,S.B., Nascimento,B., Jr., Osman,F., Netto,F.S., Kiss,A., Callum,J., Brenneman,F.D., Tremblay,L. and Tien,H.C.
    Recombinant activated coagulation factor VII and bleeding trauma patients
    J Trauma61, 1419-1425. PubMed  Europe PubMed DOI  U

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use